Results 181 to 190 of about 61,873 (295)

Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. [PDF]

Neuropsychopharmacol Rep
Saga Y, Horio H, Chiang CL, Wakamatsu A.
europepmc   +1 more source

Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia. [PDF]

Ment Health Clin, 2023
Claassen DO, Ayyagari R, García-Horton V, Zhang S, Leo S.   +4 more
europepmc   +1 more source

Unique and overlapping mechanisms of valbenazine, deutetrabenazine, and vitamin E for tardive dyskinesia. [PDF]

Schizophrenia (Heidelb)
Li C, Zhuo C, Ma X, Li R, Chen X, Li Y, Zhang Q, Yang L, Tian H, Wang L.   +9 more
europepmc   +1 more source

Zolpidem dependence for self-medication in the management of tardive dyskinesia. [PDF]

Indian J Psychiatry, 2023
Fan CY, Liu HW, Chan CH.
europepmc   +1 more source

The Role of Ultrasound in the Evaluation of Tardive Dyskinesia: A Case Series. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Roy U, Panwar A, Srivastava AK, Cartwright MS.   +3 more
europepmc   +1 more source

Caffeine inhibits Levodopa-Induced Potentiation of Haloperidol-Induced Catalepsy and Tardive Dyskinesia in Balb/ C Mice

, 2018
Premsaroj B. Bhansali, Shivraj Vhanale, Sanjay Kasture   +2 more
openalex   +1 more source

The Prevalence of Tardive Dyskinesia In Patients With Schizophrenia Treated With Antipsychotics In Malaysia. [PDF]

Neuropsychiatr Dis Treat
Nedunjelian A, Ng CG, Lim PK, Sulaiman AH, Koh OH, Francis B.   +5 more
europepmc   +1 more source

Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report [PDF]

, 2015

core   +1 more source

Association of tardive dyskinesia with variation in CYP2D6 : Is there a role for active metabolites?

, 2014
Maju Mathew Koola, Eva-Maria Tsapakis, Pádraig Wright, Shubuladè Smith, Robert Kerwin, Katie L. Nugent, Katherine J. Aitchison   +6 more
openalex   +1 more source

A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation. [PDF]

Sci Rep
Ishida M, Ichikawa R, Ohbuchi K, Oizumi H, Miyamoto Y, Yamauchi J.   +5 more
europepmc   +1 more source